Table 3. Distribution of patient... | American Society of Hematology

Table 3.

Distribution of patient characteristics by treatment assignment

Patient characteristic	Weekly		Every other week		P
Patient characteristic	N	(%)	N	(%)	P
Prior Asp hypersensitivity
No	64	(87.7)	62	(83.8)	.50^3-150
Yes	9	(12.3)	12	(16.2)
Sex
Male	48	(65.8)	45	(60.8)	.53^3-150
Female	25	(34.2)	29	(39.2)
Race
White	53	(72.6)	49	(66.2)	.40^3-150
Non-white	20	(27.4)	25	(33.8)
Type of relapse
Isolated BM	47	(83.6)	52	(86.5)
BM + EMD	19	(6.8)	12	(0.0)	.31^3-150
Isolated EMD	7	(9.6)	10	(13.5)
Duration of CR1 (y)
Mean ± SD	2.72 ± 1.83		2.74 ± 1.83		.95^3-151
Age at diagnosis (y)
Mean ± SD	6.64 ± 4.95		6.61 ± 4.56		.97^3-151
Age at relapse (y)
Mean ± SD	9.36 ± 5.07		9.35 ± 5.30		.99^3-151
WBC count at relapse (per mm³)
Median	5100		4100		.52^3-152
[interquartile range]	[3000-7700]		[2500-8200]

Patient characteristic	Weekly		Every other week		P
Patient characteristic	N	(%)	N	(%)	P
Prior Asp hypersensitivity
No	64	(87.7)	62	(83.8)	.50^3-150
Yes	9	(12.3)	12	(16.2)
Sex
Male	48	(65.8)	45	(60.8)	.53^3-150
Female	25	(34.2)	29	(39.2)
Race
White	53	(72.6)	49	(66.2)	.40^3-150
Non-white	20	(27.4)	25	(33.8)
Type of relapse
Isolated BM	47	(83.6)	52	(86.5)
BM + EMD	19	(6.8)	12	(0.0)	.31^3-150
Isolated EMD	7	(9.6)	10	(13.5)
Duration of CR1 (y)
Mean ± SD	2.72 ± 1.83		2.74 ± 1.83		.95^3-151
Age at diagnosis (y)
Mean ± SD	6.64 ± 4.95		6.61 ± 4.56		.97^3-151
Age at relapse (y)
Mean ± SD	9.36 ± 5.07		9.35 ± 5.30		.99^3-151
WBC count at relapse (per mm³)
Median	5100		4100		.52^3-152
[interquartile range]	[3000-7700]		[2500-8200]

Asp = asparaginase; BM = bone marrow; EMD = extramedullary; WBC = white blood cell count.

χ² test.

Independent samples t test.

Wilcoxon rank sum test.